Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Chengdu Kanghua Biological Products Co., Ltd.
| Okres |
2023-12-31 |
2024-12-31 |
2025-12-31 |
2026-12-31 |
| Przychód (średnia) |
1,610.65 |
1,874.72 |
2,126.90 |
2,379.30 |
| Przychód Δ r/r |
0.00% |
16.40% |
13.45% |
11.87% |
| Przychód (min) |
1,585.79 |
1,838.34 |
2,101.63 |
2,342.59 |
| Przychód (max) |
1,632.65 |
1,900.08 |
2,156.20 |
2,411.80 |
| EBITDA (średnia) |
839.06 |
976.63 |
1,108.00 |
1,239.49 |
| EBIT (średnia) |
805.92 |
938.06 |
1,064.24 |
1,190.54 |
| EBIT % |
50.04% |
50.04% |
50.04% |
50.04% |
| Zysk netto (średni) |
553.49 |
725.32 |
796.90 |
884.24 |
| Zysk netto % |
34.36% |
38.69% |
37.47% |
37.16% |
| EPS (średnia) |
4.14 |
5.39 |
5.92 |
6.57 |
| Liczba analityków (Przychody) |
2 |
3 |
4 |
5 |
| Liczba analityków (EPS) |
3 |
3 |
4 |
5 |
| symbol |
300841.SZ |
300841.SZ |
300841.SZ |
300841.SZ |